Our study shows that the expression of vitamin D-binding protein
is decreased in MM patients.
Serum vitamin D-binding protein
is a third member of the albumin and alpha fetoprotein gene family.
Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein
(DBP) gene with postmenopausal bone mineral density.
Influence of the vitamin D-binding protein
on the serum concentration of 1,25dihydroxyvitamin [D.
Comment: Vitamin D-binding protein
is the primary vitamin D carrier protein, binding 85% to 90% of circulating 25(OH)D.
3] in its natural state bound to vitamin D-binding protein
is very stable at room temperature, even for unprocessed whole blood.
Proteins identified Accession (a) Downregulated proteins 1 PRAME family member 7 PRAM7_HUMAN 2 [alpha]-1B-glycoprotein precursor A1BG_HUMAN 3 Keratin, type II cytoskeletal 1 K2C1_HUMAN 4 Neurofilament triplet L protein NFL_HUMAN 5 Vitamin D-binding protein
VTDB_HUMAN precursor 6 Protease C1 inhibitor IC1_HUMAN precursor 7 Keratin, type I cytoskeletal 10 K1C10_HUMAN 8 Complement factor B CFAB_HUMAN precursor 9 Complement C1r C1R_HUMAN subcomponent precursor 10 Transthyretin precursor TTHY_HUMAN 11 Zinc finger protein 792 ZN792_HUMAN 12 Kininogen-1 precursor KNG1_HUMAN Upregulated proteins 1 Complement factor H CFAH_HUMAN precursor 2 Apolipoprotein C-III precursor APOC3_HUMAN 3 [[alpha].
Group-specific component globulin (Gc-globulin)  also known as vitamin D-binding protein
, is a multifunctional plasma protein with a relative molecular mass ([M.
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein
These are vitamin D-binding protein
, PNP, and MDH, which increased under drug treatment, and paraoxonase and cellular retinol-binding protein, which decreased under drug treatment conditions.
In the assay described here, samples to which labeled internal standard has been added are allowed to equilibrate over an extended period of time during which the labeled compound is bound to vitamin D-binding protein
in the same manner as the target analyte.
The first routine methods for measurement of 25(OH)D concentrations in human plasma were based on competitive protein binding and used vitamin D-binding protein
and a tritium-labeled tracer (3).